1.79
+0.045(+2.58%)
Currency In USD
| Previous Close | 1.75 |
| Open | 1.76 |
| Day High | 1.8 |
| Day Low | 1.72 |
| 52-Week High | 9.19 |
| 52-Week Low | 1.61 |
| Volume | 125,777 |
| Average Volume | 135,993 |
| Market Cap | 17.04M |
| PE | -0.95 |
| EPS | -1.88 |
| Moving Average 50 Days | 1.97 |
| Moving Average 200 Days | 2.5 |
| Change | 0.05 |
If you invested $1000 in Daré Bioscience, Inc. (DARE) 10 years ago, it would be worth $4.08 as of December 04, 2025 at a share price of $1.725. Whereas If you bought $1000 worth of Daré Bioscience, Inc. (DARE) shares 5 years ago, it would be worth $95.83 as of December 04, 2025 at a share price of $1.725.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
GlobeNewswire Inc.
Dec 01, 2025 1:00 PM GMT
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced tha
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
GlobeNewswire Inc.
Nov 24, 2025 1:00 PM GMT
Grant funding will support continued progress on a preclinical research program to identify and develop a non-hormonal intravaginal contraceptive innovation aimed at addressing unmet global needsSAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Daré Bi
Daré Bioscience Highlights Commercial Launch Readiness for DARE to PLAY™ Sildenafil Cream; November 17th Webinar to Feature Leading Clinicians Discussing Clinical Data and Potential Impact in Women’s Sexual Health
GlobeNewswire Inc.
Nov 11, 2025 1:00 PM GMT
Event to Explore What Makes DARE to PLAY™ a First-of-Its-Kind Topical Sildenafil Cream for Women, Review Supporting Clinical Data, and Discuss 503B Pathway to Commercial Availability, Expected Before Year-EndSAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE